These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22998939)

  • 1. Foveal vision is impaired in Parkinson's disease.
    Bodis-Wollner I
    Parkinsonism Relat Disord; 2013 Jan; 19(1):1-14. PubMed ID: 22998939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fovea and foveation in Parkinson's disease.
    Bodis-Wollner I; Glazman S; Yerram S
    Behav Neurosci; 2013 Apr; 127(2):139-50. PubMed ID: 23356330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography in Parkinson's disease: is the retina a biomarker?
    Lee JY; Ahn J; Kim TW; Jeon BS
    J Parkinsons Dis; 2014; 4(2):197-204. PubMed ID: 24518436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoreceptor layer thinning in idiopathic Parkinson's disease.
    Roth NM; Saidha S; Zimmermann H; Brandt AU; Isensee J; Benkhellouf-Rutkowska A; Dornauer M; Kühn AA; Müller T; Calabresi PA; Paul F
    Mov Disord; 2014 Aug; 29(9):1163-70. PubMed ID: 24789530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
    Silva MF; Faria P; Regateiro FS; Forjaz V; Januário C; Freire A; Castelo-Branco M
    Brain; 2005 Oct; 128(Pt 10):2260-71. PubMed ID: 16000338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease.
    Miri S; Glazman S; Mylin L; Bodis-Wollner I
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S134-7. PubMed ID: 26414119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography.
    Slotnick S; Ding Y; Glazman S; Durbin M; Miri S; Selesnick I; Sherman J; Bodis-Wollner I
    Mov Disord; 2015 Oct; 30(12):1692-5. PubMed ID: 26340519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal nerve fiber layer thinning in Parkinson disease.
    Inzelberg R; Ramirez JA; Nisipeanu P; Ophir A
    Vision Res; 2004 Nov; 44(24):2793-7. PubMed ID: 15342223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease.
    Lee JY; Kim JM; Ahn J; Kim HJ; Jeon BS; Kim TW
    Mov Disord; 2014 Jan; 29(1):61-7. PubMed ID: 23775932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on visual function and choroidal-retinal thickness alterations in Parkinson's disease.
    Obis J; Satue M; Alarcia R; Pablo LE; Garcia-Martin E
    Arch Soc Esp Oftalmol (Engl Ed); 2018 May; 93(5):231-238. PubMed ID: 29454631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease.
    Garcia-Martin E; Satue M; Fuertes I; Otin S; Alarcia R; Herrero R; Bambo MP; Fernandez J; Pablo LE
    Ophthalmology; 2012 Oct; 119(10):2161-7. PubMed ID: 22749083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venturing into the no-man's land of the retina in Parkinson's disease.
    Bodis-Wollner I; Miri S; Glazman S
    Mov Disord; 2014 Jan; 29(1):15-22. PubMed ID: 24339212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline, one and three month changes in the peripapillary retinal nerve fiber layer in acute optic neuritis: relation to baseline vision and MRI.
    Kupersmith MJ; Mandel G; Anderson S; Meltzer DE; Kardon R
    J Neurol Sci; 2011 Sep; 308(1-2):117-23. PubMed ID: 21764408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.
    Henderson AP; Altmann DR; Trip AS; Kallis C; Jones SJ; Schlottmann PG; Garway-Heath DF; Plant GT; Miller DH
    Brain; 2010 Sep; 133(9):2592-602. PubMed ID: 20566483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual dysfunction in Parkinson's disease.
    Rodnitzky RL
    Clin Neurosci; 1998; 5(2):102-6. PubMed ID: 10785835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson's disease.
    Pinkhardt EH; Ding Y; Slotnick S; Kassubek J; Ludolph AC; Glazman S; Selesnick I; Bodis-Wollner I
    J Neural Transm (Vienna); 2020 Sep; 127(9):1275-1283. PubMed ID: 32676747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
    Saidha S; Syc SB; Durbin MK; Eckstein C; Oakley JD; Meyer SA; Conger A; Frohman TC; Newsome S; Ratchford JN; Frohman EM; Calabresi PA
    Mult Scler; 2011 Dec; 17(12):1449-63. PubMed ID: 21865411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinopathy in Parkinson Disease.
    Bodis-Wollner I
    J Neural Transm (Vienna); 2009 Nov; 116(11):1493-501. PubMed ID: 19730784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson's disease (PD).
    Nowacka B; Lubiński W; Honczarenko K; Potemkowski A; Safranow K
    Doc Ophthalmol; 2015 Oct; 131(2):95-104. PubMed ID: 25972299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.